MasterCard Affected by Processing Decline and 1 Morning Hot Stocks Not to Overlook

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

MasterCard (NYSE:MA) cites a decline in global transaction processing and currency headwinds as the reasons for slower growth in revenues in the second-half compared to what was witnessed in Q2. The warning came at an investor meet.

Don’t Miss: QE3: Hindering the Savings and Retirement Process.

In a radical move, ten top pharma firms have come together to form a non-profit organization called TransCelerate BioPharma that will accelerate drug development by co-operating on research, revamp clinical trial procedures and adopt common data recording systems that should help regulators. The participating companies include AstraZeneca (NYSE:AZN), Eli Lilly (NYSE:LLY), GSK, J&J (NYSE:JNJ) and Pfizer (NYSE:PFE).

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.



More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business